BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6561979)

  • 1. [Purification of human low molecular weight kininogen, and its application for the sensitive method of human urinary kallikrein activity].
    Kondo M; Shimamoto K; Ura N; Mita A; Nishimiya T
    Horumon To Rinsho; 1984 Jan; 32(1):91-7. PubMed ID: 6561979
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
    Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and enzyme study of kininogens I and II from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of urinary kininogenase activity using bovine serum low molecular weight kininogen.
    Abe K; Kato H; Sakurai Y; Itoh T; Saito K; Haruyama T; Otsuka Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120A():105-14. PubMed ID: 495304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Purification of kininogen II (LMW) from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):243-7. PubMed ID: 1032267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogen.
    Kondo M; Shimamoto K; Ura N; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O
    Endocrinol Jpn; 1984 Oct; 31(5):635-43. PubMed ID: 6569840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of human low molecular weight kininogen.
    Müller-Esterl W; Vohle-Timmermann M; Boos B; Dittman B
    Biochim Biophys Acta; 1982 Sep; 706(2):145-52. PubMed ID: 6922723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.
    Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O
    Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary kallikrein quantity and activity in normal pregnant women in the third trimester].
    Hiruta M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1156-60. PubMed ID: 3849561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
    Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
    Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of human high molecular weight kininogen by human plasma kallikrein.
    Nagasawa S; Nakayasu T
    Adv Exp Med Biol; 1979; 120B():163-71. PubMed ID: 517233
    [No Abstract]   [Full Text] [Related]  

  • 13. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen.
    Han YN; Kato H; Iwanaga S; Komiya M
    J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Urinary kallikrein under furosemide and plasma kininogen levels in normal and hypertensive rats.
    Croxatto HR; Roblero JS; García RL; Corthorn JH; San Martín M
    Acta Physiol Lat Am; 1973; 23(6):556-8. PubMed ID: 4795058
    [No Abstract]   [Full Text] [Related]  

  • 15. Kininogen changes in the alloxan-diabetic rat.
    Reis ML; Paschoalato R; Serra CH
    Agents Actions Suppl; 1992; 36():223-9. PubMed ID: 1609646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-kinin system in diabetic patients.
    Uehara S; Isogawa S; Sakamoto W; Hirayama A
    Arzneimittelforschung; 1988 May; 38(5):721-3. PubMed ID: 3415716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory values of kallikrein-kininogen-kinin].
    Omata K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():573-6. PubMed ID: 16149580
    [No Abstract]   [Full Text] [Related]  

  • 18. Amino acid sequence of the light chain of human high molecular mass kininogen.
    Kellermann J; Lottspeich F; Henschen A; Müller-Esterl W
    Adv Exp Med Biol; 1986; 198 Pt A():85-9. PubMed ID: 3643719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid purification of human high molecular weight kininogen.
    Habal FM; Movat HZ
    Agents Actions; 1976 Sep; 6(5):565-8. PubMed ID: 970286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
    Kamata Y; Fujita T; Kato T; Hayashi I; Kurosaka M; Katori M; Fujita Y; Majima M
    Hypertens Res; 2009 Mar; 32(3):220-6. PubMed ID: 19262486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.